Vanguard Group Inc Nutri Band Inc. Call Options Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NTRB
# of Institutions
23Shares Held
346KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA63.6KShares$463,2330.0% of portfolio
-
State Street Corp Boston, MA25KShares$181,7520.0% of portfolio
-
Haven Private, LLC Orlando, FL11.5KShares$83,8720.04% of portfolio
-
Northern Trust Corp Chicago, IL11.5KShares$83,5880.0% of portfolio
-
Consolidated Portfolio Review Corp Woodbury, NY10.4KShares$75,3480.01% of portfolio
About NutriBand Inc.
- Ticker NTRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 7,803,260
- Market Cap $56.8M
- Description
- Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid the...